Entry - #219200 - CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A - OMIM
# 219200

CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A


Alternative titles; symbols

ARCL2
CUTIS LAXA WITH CONGENITAL DISORDER OF GLYCOSYLATION
CUTIS LAXA WITH GROWTH AND DEVELOPMENTAL DELAY
CUTIS LAXA, DEBRE TYPE
CUTIS LAXA WITH BONE DYSTROPHY
CUTIS LAXA WITH JOINT LAXITY AND RETARDED DEVELOPMENT


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
12q24.31 Cutis laxa, autosomal recessive, type IIA 219200 AR 3 ATP6V0A2 611716
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
GROWTH
Other
- Intrauterine growth retardation (IUGR)
- Failure to thrive
HEAD & NECK
Head
- Microcephaly
Face
- Midface hypoplasia
- Long philtrum
- Flat face
Ears
- Low-set ears
Eyes
- Downslanting palpebral fissures
- Strabismus
- Myopia
Nose
- Short nose
- Anteverted nares
Mouth
- Small mouth
- High-arched palate
Teeth
- Dental caries
ABDOMEN
Gastrointestinal
- Feeding problems in infancy
SKELETAL
- Joint hyperextensibility
Skull
- Large anterior fontanel
- Delayed closure of the fontanel
Pelvis
- Congenital hip dislocation
SKIN, NAILS, & HAIR
Skin
- Cutis laxa
- Loose redundant skin
- Excessive skin folds
Skin Histology
- Abnormal, broken, shortened elastic fibers
- Decreased amount of elastin
Hair
- Sparse, brittle hair
- Coarse hair
MUSCLE, SOFT TISSUES
- Hypotonia
- Lipodystrophy
- Abnormal distribution of subcutaneous fat
NEUROLOGIC
Central Nervous System
- Delayed motor development
- Mental retardation
- Seizures
- Hypotonia
- Partial pachygyria
- Cobblestone lissencephaly, posterior frontal and parietal regions
- Board and poorly defined gyri
- Polymicrogyria
- Dandy-Walker malformation
LABORATORY ABNORMALITIES
- Abnormal isoelectric focusing of serum transferrin
- Defect in N- and O-glycosylation
MISCELLANEOUS
- Skin abnormalities tend to decrease with age
MOLECULAR BASIS
- Caused by mutation in the ATPase, H+ transporting, lysosomal, V0 subunit A2 gene (ATP6V0A2, 611716.0001)
Cutis laxa - PS123700 - 14 Entries
Congenital disorders of glycosylation, type I - PS212065 - 29 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.12 Congenital disorder of glycosylation, type Ir AR 3 614507 DDOST 602202
1p36.11 Retinitis pigmentosa 59 AR 3 613861 DHDDS 608172
1p36.11 ?Congenital disorder of glycosylation, type 1bb AR 3 613861 DHDDS 608172
1p31.3 Congenital disorder of glycosylation, type Ic AR 3 603147 ALG6 604566
1p31.3 Congenital disorder of glycosylation, type It AR 3 614921 PGM1 171900
1q22 Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15 AR 3 612937 DPM3 605951
3p23 Congenital disorder of glycosylation, type Ix AR 3 615597 STT3B 608605
3p21.1 Congenital disorder of glycosylation, type In AR 3 612015 RFT1 611908
3q27.1 Congenital disorder of glycosylation, type Id AR 3 601110 ALG3 608750
4q12 Congenital disorder of glycosylation, type Iq AR 3 612379 SRD5A3 611715
6q22.1 ?Congenital disorder of glycosylation, type 1aa AR 3 617082 NUS1 610463
9q22.33 Congenital disorder of glycosylation, type Ii AR 3 607906 ALG2 607905
9q34.11 Congenital disorder of glycosylation, type Iu AR 3 615042 DPM2 603564
9q34.11 Congenital disorder of glycosylation, type Im AR 3 610768 DOLK 610746
11q14.1 Congenital disorder of glycosylation, type Ih AR 3 608104 ALG8 608103
11q23.1 Congenital disorder of glycosylation, type Il AR 3 608776 ALG9 606941
11q23.3 Congenital disorder of glycosylation, type Ij AR 3 608093 DPAGT1 191350
11q24.2 Congenital disorder of glycosylation, type Iw, autosomal recessive AR 3 615596 STT3A 601134
12q24.31 Cutis laxa, autosomal recessive, type IIA AR 3 219200 ATP6V0A2 611716
13q14.3 Congenital disorder of glycosylation, type Ip AR 3 613661 ALG11 613666
15q24.1-q24.2 Congenital disorder of glycosylation, type Ib AR 3 602579 MPI 154550
16p13.3 Congenital disorder of glycosylation, type Ik AR 3 608540 ALG1 605907
16p13.2 Congenital disorder of glycosylation, type Ia AR 3 212065 PMM2 601785
17p13.1 Congenital disorder of glycosylation, type If AR 3 609180 MPDU1 604041
20q13.13 Congenital disorder of glycosylation, type Ie AR 3 608799 DPM1 603503
22q13.33 Congenital disorder of glycosylation, type Ig AR 3 607143 ALG12 607144
Xq21.1 Congenital disorder of glycosylation, type Icc XLR 3 301031 MAGT1 300715
Xq23 Developmental and epileptic encephalopathy 36 XL 3 300884 ALG13 300776
Xq28 Congenital disorder of glycosylation, type Iy XLR 3 300934 SSR4 300090

TEXT

A number sign (#) is used with this entry because autosomal recessive cutis laxa type IIA (ARCL2A) is caused by homozygous or compound heterozygous mutations in the ATP6V0A2 gene (611716), which encodes the alpha-2 subunit of the V-type H+ ATPase, on chromosome 12q24. The occurrence of mutations in the same gene in wrinkly skin syndrome (WSS; 278250) indicates that autosomal recessive cutis laxa type IIA and some cases of WSS represent variable manifestations of the same genetic defect.


Description

Autosomal recessive cutis laxa type II represents a spectrum of clinical entities with variable severity of cutis laxa, abnormal growth, developmental delay, and associated skeletal abnormalities. Aside from cutis laxa, persistent wide fontanels, frontal bossing, slight oxycephaly, downward-slanted palpebral fissures, reversed-V eyebrows, and dental caries are characteristic. Patients with ARCL2 can be divided into 2 major groups: ARCL2A, comprising those with a combined N- and O-linked glycosylation defect (CDG type II), and ARCL2B, those without a metabolic disorder (summary by Morava et al., 2009). Van Maldergem et al. (2008) concluded that ARCL2A should be considered more of a multisystem disorder with cobblestone-like brain dysgenesis manifesting as developmental delay and an epileptic neurodegenerative syndrome rather than purely a dermatologic disorder.

For a phenotypic description and a discussion of genetic heterogeneity of autosomal recessive cutis laxa, see ARCL1A (219100).

Genetic Heterogeneity of Cutis Laxa Type II

ARCL2A is caused by mutation in the ATP6V0A2 gene. ARCL2B (612940) is caused by mutation in the PYCR1 gene (179035). ARCL2C (617402) is caused by mutation in the ATP6V1E1 gene (108746). ARCL2D (617403) is caused by mutation in the ATP6V1A gene (607027). ARCL2E (619451) is caused by mutation in the LTBP1 gene (150390).


Clinical Features

Fittke (1942) described a 10.5-month-old female whose skin from birth had been in loose, redundant folds. The face was spared, however. On stretching, the skin returned only slowly to its original position. The skeletal system showed widely persistent fontanels, slight oxycephaly, and dislocation of one hip. The parents were not known to be related but lived in an area of Europe where most persons were related in some degree. The mother, aged 25 years, had long suffered from 'weak knee joints.' An 8-year-old cousin of the proband showed the same skin changes, as well as pigeon breast, static scoliosis, and flat feet. The fontanels had not closed until the third year. The case of Debre et al. (1937) may be identical. Theopold and Wildhack (1951) restudied Fittke's family and demonstrated consanguinity of the parents of the affected cousin.

Reisner et al. (1971) described 2 sisters with congenital cutis laxa associated with severe intrauterine growth retardation and congenital dislocation of the hip. The parents were first cousins. The authors suggested that the severe form may occur only or mainly in females because it is lethal to the male fetus. They also suggested that this disorder is unusually frequent in Saudi Arabia. Sakati et al. (1983) reported 6 cases, bringing the reported total to 13, all female, and raised the question of X-linked dominant lethal in the hemizygous male. However, Philip (1978) observed a case in a male infant. Fitzsimmons et al. (1985) and Goldblatt et al. (1988) also reported males with this special cutis laxa syndrome. Allanson et al. (1986) reported an affected girl with first-cousin parents of Saudi Arabian extraction.

Ogur et al. (1990) reported the cases of Turkish brother and sister. Van Maldergem et al. (1989) pictured a 23-month-old patient born to Turkish first-cousin parents. Facial features included a bossing of the forehead, reversed-V eyebrows, and downward slant of palpebral fissures. The patient also had enormous bilateral inguinal hernias. Imaizumi et al. (1994) described a nineteenth case; the ratio of males to females was 5 to 14. Their patient, a 5-year-old boy, had pre- and postnatal growth retardation, delayed motor development, cutis laxa, delayed closure of large fontanels, congenital hip dislocation, and characteristic facies.

Based on a previous observation of an abnormal transferrin isoelectric focusing pattern in a patient with cutis laxa indicating an N-glycosylation defect, Morava et al. (2005) performed a screening for disorders of protein glycosylation in unrelated children with cutis laxa syndrome. They described 5 patients from consanguineous marriages with a cutis laxa syndrome with skeletal and joint involvement, developmental delay, and neurologic findings. Three of these 5 children had an inborn error of glycan biosynthesis affecting the synthesis of both N- and O-linked glycans, and 2 of these patients had bilateral pachygyria on brain MRI. Two patients had normal glycosylation patterns. All known causes of secondary glycosylation disorders were excluded in the children. No mutations were identified in the FBLN5 gene (604580). Morava et al. (2005) concluded that these patients had a unique combined glycosylation defect with a distinct clinical phenotype and that a combined defect of glycosylation may be a causative factor in autosomal recessive congenital cutis laxa.

Morava et al. (2008) described 10 patients with cutis laxa and congenital disorder of glycosylation, including 3 patients reported by Morava et al. (2005). Clinical features included transient feeding problems in infancy, late closure of the fontanelles, and variable central nervous system involvement including hypotonia, developmental delay, mental retardation, seizures, microcephaly, pachygyria, and myopia. All patients had dysmorphic facial features with downslanting palpebral fissures, midface hypoplasia, anteverted nares, short nose and small mouth. Other features included congenital hip dislocation and joint hyperlaxity. Skin biopsy showed decreased amounts of elastin and abnormal elastin structure. Biochemical analysis showed a combined defect of N- and O-glycosylation. All patients had mutations in the ATP6V0A2 gene (Kornak et al., 2008).

Van Maldergem et al. (2008) reported 11 patients from 9 families with the Debre type of cutis laxa, which was confirmed by genetic analysis of the ATP6V0A2 in all patients except 1. All had dysmorphic craniofacial features, most commonly including large anterior fontanel, prominent supraorbital ridges and nasal root, downslanting palpebral fissures, and coarse hair. Four patients had microcephaly. The skin showed generalized overfolding and wrinkling, but no hyperelasticity, and skin biopsies showed a sparse elastin network. Connective tissue problems were common, and included inguinal hernia, hip dislocation, and high myopia. There tended to be improvement of cutis laxa throughout childhood. All had mental retardation that varied in severity, and 5 patients developed refractory seizures. Transferrin isoelectric focusing showed CDG type II. Brain imaging was performed in 9 patients, 8 of whom showed a cobblestone-like malformation predominantly in the posterior frontal, perisylvian, and parietal regions. It resembled polymicrogyria, but the cortical ribbon appeared smooth in some areas and irregular in others. These cortical malformations were reminiscent of those observed in the alpha-dystroglycanopathies, such as Walker-Warburg syndrome (see, e.g., MDDGA1, 236670). Two patients had a Dandy-Walker malformation.

Morava et al. (2009) reviewed the spectrum of clinical features of the various autosomal recessive syndromes associated with cutis laxa, including ARCL1 (219100), ARCL2, de Barsy syndrome (219150), X-linked cutis laxa (304150), WSS, geroderma osteodysplasticum (GO; 231070), and Costello syndrome (218040).

Relationship to Wrinkly Skin Syndrome

Zlotogora (1999) pointed out that the 2 sisters reported by Reisner et al. (1971) as one of the first examples of the syndrome of cutis laxa with growth and developmental delay were reported later, along with their newborn brother, as examples of WSS. Conformation that these 2 syndromes represent variable presentations of one disorder may be provided by the report of Ogur et al. (1990) on 2 affected Turkish sibs. The boy was severely affected with the classic form of cutis laxa and developmental delay, while his sister showed improvement with the years and at the age of 6.5 years presented with a relatively mild disease, including cutaneous manifestations similar to those found in the wrinkly skin syndrome. Another source of confusion is that some of the children reported with recessive infantile cutis laxa with growth and developmental delay were, in fact, affected with Costello syndrome (see later). Since the wrinkly skin syndrome is not a true form of cutis laxa (Azuri et al., 1999), Zlotogora (1999) suggested use of the designation 'wrinkly skin syndrome' for all of the patients who were reported as affected with either one or the other of these 2 syndromes.


Pathogenesis

Congenital disorders of glycosylation (CDG) form a growing class of hereditary disorders caused by defective glycosylation at the level of the endoplasmic reticulum or the Golgi apparatus (Freeze, 2006). An association of a cutis laxa phenotype with CDG has been described (Morava et al., 2005), and wrinkly skin has been observed in an individual with a defect in the conserved oligomeric Golgi (COG) complex (Wu et al., 2004). On the basis of these observations, Kornak et al. (2008) investigated glycosylation of serum proteins isolated from individuals with autosomal recessive cutis laxa type II and found that they showed a CDG type II pattern, which corresponds to a defect of N-glycosylation at the level of processing in the Golgi apparatus. Reduced sialic acid content of the glycans from affected individuals indicated that sialylation, a terminal step of glycan synthesis, was particularly impaired. A strict correlation between phenotype and degree of glycan abnormality was not seen.


Mapping

In 15 consanguineous families with a cutis laxa or wrinkly skin syndrome phenotype, Kornak et al. (2008) performed homozygosity mapping, microsatellite marker analysis, and haplotype analysis and identified a 5.7-Mb region of homozygosity on chromosome 12q24 between markers D12S395 and D12S304 containing the ATP6V0A2 gene.


Molecular Genetics

In 12 families with diagnoses of either autosomal recessive cutis laxa type II or wrinkly skin syndrome, Kornak et al. (2008) identified 10 different loss-of-function mutations in the ATP6V0A2 gene. The mutations resulted in abnormal glycosylation of serum proteins (CDG II) and caused an impairment of Golgi trafficking in fibroblasts from affected individuals. The results indicated that the alpha-2 subunit of the proton pump has an important role in the Golgi function.

Leao-Teles et al. (2010) stated that 1 of the patients studied by Kornak et al. (2008) and found to have a mutation in the ATP6V0A2 gene (patient 'CoFe') displayed the full clinical picture of the De Barsy syndrome (see 219150), including cutis laxa, facial dysmorphism, dwarfism, psychomotor retardation, dystonia, congenital hip dysplasia, and corneal dystrophy requiring repeated corneal transplantation. Leao-Teles et al. (2010) suggested that a subgroup of patients with de Barsy syndrome belongs to the spectrum of ATP6V0A2-associated CDG, and recommended that mutations in the ATP6V0A2 gene be sought in patients diagnosed with de Barsy syndrome. Morava et al. (2010) noted that none of their cohort of 6 patients with de Barsy syndrome had N-linked or O-linked glycosylation abnormalities nor mutations in ATP6V0A2; they stated that further description and photographs of patient CoFe would be helpful, since corneal abnormalities with a movement disorder would widen the range of symptoms evoking glycosylation studies in patients with cutis laxa.

In 13 patients with ARCL2, Fischer et al. (2012) identified 17 ATP6V0A2 mutations: 1 mutation of the start codon, 3 missense mutations, 3 nonsense mutations, 3 splice site mutations, 3 in-frame deletions, and 4 frameshift mutations; 14 of the mutations were novel. All mutations but 1 were found in homozygous or compound heterozygous state. A heterozygous mutation was detected at the genomic as well as the cDNA level in a 40-year-old patient (patient 2), but a pronounced nonsense-mediated decay of the ATP6V0A2 mRNA in fibroblasts corroborated an ATP6V0A2-related ARCL2. Fischer et al. (2012) suggested that the second mutation most probably resided in noncoding regions not included in the mutation screening. This patient, who was described as the oldest affected individual reported to that time, showed a strikingly progressive phenotype leading to kyphoscoliosis, facial coarsening, mild to moderate mental retardation, and seizures without progression.


Heterogeneity

Exclusion Studies

In 3 unrelated patients with autosomal recessive cutis laxa type II, Scherrer et al. (2008) excluded mutations in the FBLN4 (604633), FBLN5 (604580), and LOX (153455) genes. The ATP6V0A2 gene was not studied in these patients.


History

Under the title 'congenital cutis laxa with retardation of growth and development,' Patton et al. (1987) reported 7 patients. Autosomal recessive inheritance was supported by the inclusion of 2 brother-sister pairs. In 1 of these, the parents were second cousins from the Middle East. The authors were impressed with the occurrence of widespread dental caries. Later, Patton and Baraitser (1993) reviewed 5 of the cases and concluded that the appropriate diagnosis was Costello syndrome (218040). Davies and Hughes (1994) reviewed case 7 from the paper and, on both history and clinical examination, made 'an unequivocal diagnosis of Costello syndrome.'


REFERENCES

  1. Allanson, J., Austin, W., Hecht, F. Congenital cutis laxa with retardation of growth and motor development: a recessive disorder of connective tissue with male lethality. Clin. Genet. 29: 133-136, 1986. [PubMed: 2420495, related citations] [Full Text]

  2. Azuri, J., Mizrachi, A., Weintraub, S., Lerman-Sagie, T. Neurological involvement in a child with the wrinkly skin syndrome. Am. J. Med. Genet. 82: 31-33, 1999. [PubMed: 9916839, related citations]

  3. Davies, S. J., Hughes, H. E. Cutis laxa: a feature of Costello syndrome. (Letter) J. Med. Genet. 31: 85 only, 1994. [PubMed: 7512146, related citations] [Full Text]

  4. Debre, R., Marie, J., Seringe, P. 'Cutis laxa' avec dystrophies osseuses. Bull. Mem. Soc. Med. Hop. Paris 53: 1038-1039, 1937.

  5. Fischer, B., Dimopoulou, A., Egerer, J., Gardeitchik, T., Kidd, A., Jost, D., Kayserili, H., Alanay, Y., Tantcheva-Poor, I., Mangold, E., Daumer-Haas, C., Phadke, S., and 13 others. Further characterization of ATP6V0A2-related autosomal recessive cutis laxa. Hum. Genet. 131: 1761-1773, 2012. [PubMed: 22773132, related citations] [Full Text]

  6. Fittke, H. Ueber eine ungewoehnliche Form 'multipler Erbabartung' (Chalodermie und Dysostose). Z. Kinderheilk. 63: 510-523, 1942.

  7. Fitzsimmons, J. S., Fitzsimmons, E. M., Guibert, P. R., Zaldua, V., Dodd, K. L. Variable clinical presentation of cutis laxa. Clin. Genet. 28: 284-295, 1985. [PubMed: 4064367, related citations] [Full Text]

  8. Freeze, H. H. Genetic defects in the human glycome. Nature Rev. Genet. 7: 537-551, 2006. Note: Erratum: Nature Rev. Genet. 7: 660 only, 2006. [PubMed: 16755287, related citations] [Full Text]

  9. Goldblatt, J., Wallis, C., Viljoen, D., Beighton, P. Cutis laxa, retarded development and joint hypermobility syndrome. Dysmorph. Clin. Genet. 1: 142-144, 1988.

  10. Imaizumi, K., Kurosawa, K., Makita, Y., Masuno, M., Kuroki, Y. Male with type II autosomal recessive cutis laxa. Clin. Genet. 45: 40-43, 1994. [PubMed: 8149651, related citations] [Full Text]

  11. Kornak, U., Reynders, E., Dimopoulou, A., van Reeuwijk, J., Fischer, B., Rajab, A., Budde, B., Nurnberg, P., Foulquier, F., ARCL Debre-type Study Group, Lefeber, D., Urban, Z., and 9 others. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H(+)-ATPase subunit ATP6V0A2. Nature Genet. 40: 32-34, 2008. [PubMed: 18157129, related citations] [Full Text]

  12. Leao-Teles, E., Quelhas, D., Vilarinho, L., Jacken, J. De Barsy syndrome and ATP6V0A2-CDG. (Letter) Europ. J. Hum. Genet. 18: 526 only, 2010. [PubMed: 20010974, related citations] [Full Text]

  13. Morava, E., Guillard, M., Lefeber, D. J., Wevers, R. A. Autosomal recessive cutis laxa syndrome revisited. Europ. J. Hum. Genet. 17: 1099-1110, 2009. [PubMed: 19401719, images, related citations] [Full Text]

  14. Morava, E., Guillard, M., Lefeber, D. J., Wevers, R. A. Reply to Leao-Teles et al. (Letter) Europ. J. Hum. Genet. 18: 526 only, 2010.

  15. Morava, E., Lefeber, D. J., Urban, Z., de Meileir, L., Meinecke, P., Gillessen Kaesbach, G., Sykut-Cegielska, J., Adamowicz, M., Salafsky, I., Ranells, J., Lemyre, E., van Reeuwijk, J., Brunner, H. G., Wevers, R. A. Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation. Europ. J. Hum. Genet. 16: 28-35, 2008. [PubMed: 17971833, related citations] [Full Text]

  16. Morava, E., Wopereis, S., Coucke, P., Gillessen-Kaesbach, G., Voit, T., Smeitink, J., Wevers, R., Grunewald, S. Defective protein glycosylation in patients with cutis laxa syndrome. Europ. J. Hum. Genet. 13: 414-421, 2005. [PubMed: 15657616, related citations] [Full Text]

  17. Ogur, G., Yuksel-Apak, M., Demiryont, M. Syndrome of congenital cutis laxa with ligamentous laxity and delayed development: report of a brother and sister from Turkey. Am. J. Med. Genet. 37: 6-9, 1990. [PubMed: 1700609, related citations] [Full Text]

  18. Patton, M. A., Baraitser, M. Cutis laxa and the Costello syndrome. J. Med. Genet. 30: 622 only, 1993. [PubMed: 8411045, related citations] [Full Text]

  19. Patton, M. A., Tolmie, J., Ruthnum, P., Bamforth, S., Baraitser, M., Pembrey, M. Congenital cutis laxa with retardation of growth and development. J. Med. Genet. 24: 556-561, 1987. [PubMed: 3669050, related citations] [Full Text]

  20. Philip, A. G. S. Cutis laxa with intrauterine growth retardation and hip dislocation in a male. J. Pediat. 93: 150-151, 1978. [PubMed: 565809, related citations] [Full Text]

  21. Reisner, S. H., Seelenfreund, M., Ben-Bassat, M. Cutis laxa associated with severe intrauterine growth retardation and congenital dislocation of the hip. Acta Paediat. Scand. 60: 357-360, 1971. [PubMed: 5579863, related citations] [Full Text]

  22. Sakati, N. O., Nyhan, W. L., Shear, C. S., Kattan, H., Akhtar, M., Bay, C., Jones, K. L., Schackner, L. Syndrome of cutis laxa, ligamentous laxity, and delayed development. Pediatrics 72: 850-856, 1983.

  23. Scherrer, D. Z., Alexandrino, F., Cintra, M. L., Sartorato, E. L., Steiner, C. E. Type II autosomal recessive cutis laxa: report of another patient and molecular studies concerning three candidate genes. Am. J. Med. Genet. 146A: 2740-2745, 2008. [PubMed: 18819152, related citations] [Full Text]

  24. Theopold, W., Wildhack, R. Dermatochalasis in Rahmen multipler Abartungen. Mschr. Kinderheilk. 99: 213-218, 1951.

  25. Van Maldergem, L., Ogur, G., Yuksel, M. Facial anomalies in congenital cutis laxa with retarded growth and skeletal dysplasia. (Letter) Am. J. Med. Genet. 32: 265 only, 1989. [PubMed: 2929668, related citations] [Full Text]

  26. Van Maldergem, L., Yuksel-Apak, M., Kayserili, H., Seemanova, E., Giurgea, S., Basel-Vanagaite, L., Leao-Teles, E., Vigneron, J., Foulon, M., Greally, M., Jaeken, J., Mundlos, S., Dobyns, W. B. Cobblestone-like brain dysgenesis and altered glycosylation in congenital cutis laxa, Debre type. Neurology 71: 1602-1608, 2008. [PubMed: 18716235, related citations] [Full Text]

  27. Wu, X., Steet, R. A., Bohorov, O., Bakker, J., Newell, J., Krieger, M., Spaapen, L., Kornfeld, S., Freeze, H. H. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nature Med. 10: 518-523, 2004. [PubMed: 15107842, related citations] [Full Text]

  28. Zlotogora, J. Wrinkly skin syndrome and the syndrome of cutis laxa with growth and developmental delay represent the same disorder. (Letter) Am. J. Med. Genet. 85: 194 only, 1999. [PubMed: 10406678, related citations] [Full Text]


Cassandra L. Kniffin - updated : 3/14/2013
Nara Sobreira - updated : 1/29/2013
Marla J. F. O'Neill - updated : 1/31/2012
Marla J. F. O'Neill - updated : 1/27/2010
Cassandra L. Kniffin - updated : 7/21/2009
Cassandra L. Kniffin - updated : 3/24/2008
Victor A. McKusick - updated : 1/29/2008
Victor A. McKusick - updated : 7/20/1999
Creation Date:
Victor A. McKusick : 6/3/1986
alopez : 07/21/2021
alopez : 03/27/2017
carol : 10/14/2016
carol : 10/19/2015
carol : 9/30/2015
joanna : 7/18/2014
carol : 3/18/2013
terry : 3/14/2013
ckniffin : 3/14/2013
carol : 1/29/2013
alopez : 1/31/2012
alopez : 1/26/2012
alopez : 1/20/2012
joanna : 5/17/2011
wwang : 1/28/2010
terry : 1/27/2010
wwang : 9/3/2009
wwang : 8/12/2009
ckniffin : 7/29/2009
ckniffin : 7/21/2009
carol : 11/25/2008
terry : 6/4/2008
carol : 5/2/2008
carol : 5/2/2008
ckniffin : 3/24/2008
alopez : 2/8/2008
terry : 1/29/2008
alopez : 5/23/2006
carol : 4/20/2006
carol : 4/19/2006
ckniffin : 4/10/2006
jlewis : 8/2/1999
jlewis : 8/2/1999
terry : 7/20/1999
pfoster : 8/18/1994
carol : 4/15/1994
mimadm : 2/19/1994
supermim : 3/16/1992
carol : 10/23/1990
supermim : 3/20/1990

# 219200

CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A


Alternative titles; symbols

ARCL2
CUTIS LAXA WITH CONGENITAL DISORDER OF GLYCOSYLATION
CUTIS LAXA WITH GROWTH AND DEVELOPMENTAL DELAY
CUTIS LAXA, DEBRE TYPE
CUTIS LAXA WITH BONE DYSTROPHY
CUTIS LAXA WITH JOINT LAXITY AND RETARDED DEVELOPMENT


SNOMEDCT: 784381008;   ORPHA: 357058, 357074;   DO: 0070134;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
12q24.31 Cutis laxa, autosomal recessive, type IIA 219200 Autosomal recessive 3 ATP6V0A2 611716

TEXT

A number sign (#) is used with this entry because autosomal recessive cutis laxa type IIA (ARCL2A) is caused by homozygous or compound heterozygous mutations in the ATP6V0A2 gene (611716), which encodes the alpha-2 subunit of the V-type H+ ATPase, on chromosome 12q24. The occurrence of mutations in the same gene in wrinkly skin syndrome (WSS; 278250) indicates that autosomal recessive cutis laxa type IIA and some cases of WSS represent variable manifestations of the same genetic defect.


Description

Autosomal recessive cutis laxa type II represents a spectrum of clinical entities with variable severity of cutis laxa, abnormal growth, developmental delay, and associated skeletal abnormalities. Aside from cutis laxa, persistent wide fontanels, frontal bossing, slight oxycephaly, downward-slanted palpebral fissures, reversed-V eyebrows, and dental caries are characteristic. Patients with ARCL2 can be divided into 2 major groups: ARCL2A, comprising those with a combined N- and O-linked glycosylation defect (CDG type II), and ARCL2B, those without a metabolic disorder (summary by Morava et al., 2009). Van Maldergem et al. (2008) concluded that ARCL2A should be considered more of a multisystem disorder with cobblestone-like brain dysgenesis manifesting as developmental delay and an epileptic neurodegenerative syndrome rather than purely a dermatologic disorder.

For a phenotypic description and a discussion of genetic heterogeneity of autosomal recessive cutis laxa, see ARCL1A (219100).

Genetic Heterogeneity of Cutis Laxa Type II

ARCL2A is caused by mutation in the ATP6V0A2 gene. ARCL2B (612940) is caused by mutation in the PYCR1 gene (179035). ARCL2C (617402) is caused by mutation in the ATP6V1E1 gene (108746). ARCL2D (617403) is caused by mutation in the ATP6V1A gene (607027). ARCL2E (619451) is caused by mutation in the LTBP1 gene (150390).


Clinical Features

Fittke (1942) described a 10.5-month-old female whose skin from birth had been in loose, redundant folds. The face was spared, however. On stretching, the skin returned only slowly to its original position. The skeletal system showed widely persistent fontanels, slight oxycephaly, and dislocation of one hip. The parents were not known to be related but lived in an area of Europe where most persons were related in some degree. The mother, aged 25 years, had long suffered from 'weak knee joints.' An 8-year-old cousin of the proband showed the same skin changes, as well as pigeon breast, static scoliosis, and flat feet. The fontanels had not closed until the third year. The case of Debre et al. (1937) may be identical. Theopold and Wildhack (1951) restudied Fittke's family and demonstrated consanguinity of the parents of the affected cousin.

Reisner et al. (1971) described 2 sisters with congenital cutis laxa associated with severe intrauterine growth retardation and congenital dislocation of the hip. The parents were first cousins. The authors suggested that the severe form may occur only or mainly in females because it is lethal to the male fetus. They also suggested that this disorder is unusually frequent in Saudi Arabia. Sakati et al. (1983) reported 6 cases, bringing the reported total to 13, all female, and raised the question of X-linked dominant lethal in the hemizygous male. However, Philip (1978) observed a case in a male infant. Fitzsimmons et al. (1985) and Goldblatt et al. (1988) also reported males with this special cutis laxa syndrome. Allanson et al. (1986) reported an affected girl with first-cousin parents of Saudi Arabian extraction.

Ogur et al. (1990) reported the cases of Turkish brother and sister. Van Maldergem et al. (1989) pictured a 23-month-old patient born to Turkish first-cousin parents. Facial features included a bossing of the forehead, reversed-V eyebrows, and downward slant of palpebral fissures. The patient also had enormous bilateral inguinal hernias. Imaizumi et al. (1994) described a nineteenth case; the ratio of males to females was 5 to 14. Their patient, a 5-year-old boy, had pre- and postnatal growth retardation, delayed motor development, cutis laxa, delayed closure of large fontanels, congenital hip dislocation, and characteristic facies.

Based on a previous observation of an abnormal transferrin isoelectric focusing pattern in a patient with cutis laxa indicating an N-glycosylation defect, Morava et al. (2005) performed a screening for disorders of protein glycosylation in unrelated children with cutis laxa syndrome. They described 5 patients from consanguineous marriages with a cutis laxa syndrome with skeletal and joint involvement, developmental delay, and neurologic findings. Three of these 5 children had an inborn error of glycan biosynthesis affecting the synthesis of both N- and O-linked glycans, and 2 of these patients had bilateral pachygyria on brain MRI. Two patients had normal glycosylation patterns. All known causes of secondary glycosylation disorders were excluded in the children. No mutations were identified in the FBLN5 gene (604580). Morava et al. (2005) concluded that these patients had a unique combined glycosylation defect with a distinct clinical phenotype and that a combined defect of glycosylation may be a causative factor in autosomal recessive congenital cutis laxa.

Morava et al. (2008) described 10 patients with cutis laxa and congenital disorder of glycosylation, including 3 patients reported by Morava et al. (2005). Clinical features included transient feeding problems in infancy, late closure of the fontanelles, and variable central nervous system involvement including hypotonia, developmental delay, mental retardation, seizures, microcephaly, pachygyria, and myopia. All patients had dysmorphic facial features with downslanting palpebral fissures, midface hypoplasia, anteverted nares, short nose and small mouth. Other features included congenital hip dislocation and joint hyperlaxity. Skin biopsy showed decreased amounts of elastin and abnormal elastin structure. Biochemical analysis showed a combined defect of N- and O-glycosylation. All patients had mutations in the ATP6V0A2 gene (Kornak et al., 2008).

Van Maldergem et al. (2008) reported 11 patients from 9 families with the Debre type of cutis laxa, which was confirmed by genetic analysis of the ATP6V0A2 in all patients except 1. All had dysmorphic craniofacial features, most commonly including large anterior fontanel, prominent supraorbital ridges and nasal root, downslanting palpebral fissures, and coarse hair. Four patients had microcephaly. The skin showed generalized overfolding and wrinkling, but no hyperelasticity, and skin biopsies showed a sparse elastin network. Connective tissue problems were common, and included inguinal hernia, hip dislocation, and high myopia. There tended to be improvement of cutis laxa throughout childhood. All had mental retardation that varied in severity, and 5 patients developed refractory seizures. Transferrin isoelectric focusing showed CDG type II. Brain imaging was performed in 9 patients, 8 of whom showed a cobblestone-like malformation predominantly in the posterior frontal, perisylvian, and parietal regions. It resembled polymicrogyria, but the cortical ribbon appeared smooth in some areas and irregular in others. These cortical malformations were reminiscent of those observed in the alpha-dystroglycanopathies, such as Walker-Warburg syndrome (see, e.g., MDDGA1, 236670). Two patients had a Dandy-Walker malformation.

Morava et al. (2009) reviewed the spectrum of clinical features of the various autosomal recessive syndromes associated with cutis laxa, including ARCL1 (219100), ARCL2, de Barsy syndrome (219150), X-linked cutis laxa (304150), WSS, geroderma osteodysplasticum (GO; 231070), and Costello syndrome (218040).

Relationship to Wrinkly Skin Syndrome

Zlotogora (1999) pointed out that the 2 sisters reported by Reisner et al. (1971) as one of the first examples of the syndrome of cutis laxa with growth and developmental delay were reported later, along with their newborn brother, as examples of WSS. Conformation that these 2 syndromes represent variable presentations of one disorder may be provided by the report of Ogur et al. (1990) on 2 affected Turkish sibs. The boy was severely affected with the classic form of cutis laxa and developmental delay, while his sister showed improvement with the years and at the age of 6.5 years presented with a relatively mild disease, including cutaneous manifestations similar to those found in the wrinkly skin syndrome. Another source of confusion is that some of the children reported with recessive infantile cutis laxa with growth and developmental delay were, in fact, affected with Costello syndrome (see later). Since the wrinkly skin syndrome is not a true form of cutis laxa (Azuri et al., 1999), Zlotogora (1999) suggested use of the designation 'wrinkly skin syndrome' for all of the patients who were reported as affected with either one or the other of these 2 syndromes.


Pathogenesis

Congenital disorders of glycosylation (CDG) form a growing class of hereditary disorders caused by defective glycosylation at the level of the endoplasmic reticulum or the Golgi apparatus (Freeze, 2006). An association of a cutis laxa phenotype with CDG has been described (Morava et al., 2005), and wrinkly skin has been observed in an individual with a defect in the conserved oligomeric Golgi (COG) complex (Wu et al., 2004). On the basis of these observations, Kornak et al. (2008) investigated glycosylation of serum proteins isolated from individuals with autosomal recessive cutis laxa type II and found that they showed a CDG type II pattern, which corresponds to a defect of N-glycosylation at the level of processing in the Golgi apparatus. Reduced sialic acid content of the glycans from affected individuals indicated that sialylation, a terminal step of glycan synthesis, was particularly impaired. A strict correlation between phenotype and degree of glycan abnormality was not seen.


Mapping

In 15 consanguineous families with a cutis laxa or wrinkly skin syndrome phenotype, Kornak et al. (2008) performed homozygosity mapping, microsatellite marker analysis, and haplotype analysis and identified a 5.7-Mb region of homozygosity on chromosome 12q24 between markers D12S395 and D12S304 containing the ATP6V0A2 gene.


Molecular Genetics

In 12 families with diagnoses of either autosomal recessive cutis laxa type II or wrinkly skin syndrome, Kornak et al. (2008) identified 10 different loss-of-function mutations in the ATP6V0A2 gene. The mutations resulted in abnormal glycosylation of serum proteins (CDG II) and caused an impairment of Golgi trafficking in fibroblasts from affected individuals. The results indicated that the alpha-2 subunit of the proton pump has an important role in the Golgi function.

Leao-Teles et al. (2010) stated that 1 of the patients studied by Kornak et al. (2008) and found to have a mutation in the ATP6V0A2 gene (patient 'CoFe') displayed the full clinical picture of the De Barsy syndrome (see 219150), including cutis laxa, facial dysmorphism, dwarfism, psychomotor retardation, dystonia, congenital hip dysplasia, and corneal dystrophy requiring repeated corneal transplantation. Leao-Teles et al. (2010) suggested that a subgroup of patients with de Barsy syndrome belongs to the spectrum of ATP6V0A2-associated CDG, and recommended that mutations in the ATP6V0A2 gene be sought in patients diagnosed with de Barsy syndrome. Morava et al. (2010) noted that none of their cohort of 6 patients with de Barsy syndrome had N-linked or O-linked glycosylation abnormalities nor mutations in ATP6V0A2; they stated that further description and photographs of patient CoFe would be helpful, since corneal abnormalities with a movement disorder would widen the range of symptoms evoking glycosylation studies in patients with cutis laxa.

In 13 patients with ARCL2, Fischer et al. (2012) identified 17 ATP6V0A2 mutations: 1 mutation of the start codon, 3 missense mutations, 3 nonsense mutations, 3 splice site mutations, 3 in-frame deletions, and 4 frameshift mutations; 14 of the mutations were novel. All mutations but 1 were found in homozygous or compound heterozygous state. A heterozygous mutation was detected at the genomic as well as the cDNA level in a 40-year-old patient (patient 2), but a pronounced nonsense-mediated decay of the ATP6V0A2 mRNA in fibroblasts corroborated an ATP6V0A2-related ARCL2. Fischer et al. (2012) suggested that the second mutation most probably resided in noncoding regions not included in the mutation screening. This patient, who was described as the oldest affected individual reported to that time, showed a strikingly progressive phenotype leading to kyphoscoliosis, facial coarsening, mild to moderate mental retardation, and seizures without progression.


Heterogeneity

Exclusion Studies

In 3 unrelated patients with autosomal recessive cutis laxa type II, Scherrer et al. (2008) excluded mutations in the FBLN4 (604633), FBLN5 (604580), and LOX (153455) genes. The ATP6V0A2 gene was not studied in these patients.


History

Under the title 'congenital cutis laxa with retardation of growth and development,' Patton et al. (1987) reported 7 patients. Autosomal recessive inheritance was supported by the inclusion of 2 brother-sister pairs. In 1 of these, the parents were second cousins from the Middle East. The authors were impressed with the occurrence of widespread dental caries. Later, Patton and Baraitser (1993) reviewed 5 of the cases and concluded that the appropriate diagnosis was Costello syndrome (218040). Davies and Hughes (1994) reviewed case 7 from the paper and, on both history and clinical examination, made 'an unequivocal diagnosis of Costello syndrome.'


REFERENCES

  1. Allanson, J., Austin, W., Hecht, F. Congenital cutis laxa with retardation of growth and motor development: a recessive disorder of connective tissue with male lethality. Clin. Genet. 29: 133-136, 1986. [PubMed: 2420495] [Full Text: https://doi.org/10.1111/j.1399-0004.1986.tb01236.x]

  2. Azuri, J., Mizrachi, A., Weintraub, S., Lerman-Sagie, T. Neurological involvement in a child with the wrinkly skin syndrome. Am. J. Med. Genet. 82: 31-33, 1999. [PubMed: 9916839]

  3. Davies, S. J., Hughes, H. E. Cutis laxa: a feature of Costello syndrome. (Letter) J. Med. Genet. 31: 85 only, 1994. [PubMed: 7512146] [Full Text: https://doi.org/10.1136/jmg.31.1.85]

  4. Debre, R., Marie, J., Seringe, P. 'Cutis laxa' avec dystrophies osseuses. Bull. Mem. Soc. Med. Hop. Paris 53: 1038-1039, 1937.

  5. Fischer, B., Dimopoulou, A., Egerer, J., Gardeitchik, T., Kidd, A., Jost, D., Kayserili, H., Alanay, Y., Tantcheva-Poor, I., Mangold, E., Daumer-Haas, C., Phadke, S., and 13 others. Further characterization of ATP6V0A2-related autosomal recessive cutis laxa. Hum. Genet. 131: 1761-1773, 2012. [PubMed: 22773132] [Full Text: https://doi.org/10.1007/s00439-012-1197-8]

  6. Fittke, H. Ueber eine ungewoehnliche Form 'multipler Erbabartung' (Chalodermie und Dysostose). Z. Kinderheilk. 63: 510-523, 1942.

  7. Fitzsimmons, J. S., Fitzsimmons, E. M., Guibert, P. R., Zaldua, V., Dodd, K. L. Variable clinical presentation of cutis laxa. Clin. Genet. 28: 284-295, 1985. [PubMed: 4064367] [Full Text: https://doi.org/10.1111/j.1399-0004.1985.tb00402.x]

  8. Freeze, H. H. Genetic defects in the human glycome. Nature Rev. Genet. 7: 537-551, 2006. Note: Erratum: Nature Rev. Genet. 7: 660 only, 2006. [PubMed: 16755287] [Full Text: https://doi.org/10.1038/nrg1894]

  9. Goldblatt, J., Wallis, C., Viljoen, D., Beighton, P. Cutis laxa, retarded development and joint hypermobility syndrome. Dysmorph. Clin. Genet. 1: 142-144, 1988.

  10. Imaizumi, K., Kurosawa, K., Makita, Y., Masuno, M., Kuroki, Y. Male with type II autosomal recessive cutis laxa. Clin. Genet. 45: 40-43, 1994. [PubMed: 8149651] [Full Text: https://doi.org/10.1111/j.1399-0004.1994.tb03988.x]

  11. Kornak, U., Reynders, E., Dimopoulou, A., van Reeuwijk, J., Fischer, B., Rajab, A., Budde, B., Nurnberg, P., Foulquier, F., ARCL Debre-type Study Group, Lefeber, D., Urban, Z., and 9 others. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H(+)-ATPase subunit ATP6V0A2. Nature Genet. 40: 32-34, 2008. [PubMed: 18157129] [Full Text: https://doi.org/10.1038/ng.2007.45]

  12. Leao-Teles, E., Quelhas, D., Vilarinho, L., Jacken, J. De Barsy syndrome and ATP6V0A2-CDG. (Letter) Europ. J. Hum. Genet. 18: 526 only, 2010. [PubMed: 20010974] [Full Text: https://doi.org/10.1038/ejhg.2009.218]

  13. Morava, E., Guillard, M., Lefeber, D. J., Wevers, R. A. Autosomal recessive cutis laxa syndrome revisited. Europ. J. Hum. Genet. 17: 1099-1110, 2009. [PubMed: 19401719] [Full Text: https://doi.org/10.1038/ejhg.2009.22]

  14. Morava, E., Guillard, M., Lefeber, D. J., Wevers, R. A. Reply to Leao-Teles et al. (Letter) Europ. J. Hum. Genet. 18: 526 only, 2010.

  15. Morava, E., Lefeber, D. J., Urban, Z., de Meileir, L., Meinecke, P., Gillessen Kaesbach, G., Sykut-Cegielska, J., Adamowicz, M., Salafsky, I., Ranells, J., Lemyre, E., van Reeuwijk, J., Brunner, H. G., Wevers, R. A. Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation. Europ. J. Hum. Genet. 16: 28-35, 2008. [PubMed: 17971833] [Full Text: https://doi.org/10.1038/sj.ejhg.5201947]

  16. Morava, E., Wopereis, S., Coucke, P., Gillessen-Kaesbach, G., Voit, T., Smeitink, J., Wevers, R., Grunewald, S. Defective protein glycosylation in patients with cutis laxa syndrome. Europ. J. Hum. Genet. 13: 414-421, 2005. [PubMed: 15657616] [Full Text: https://doi.org/10.1038/sj.ejhg.5201361]

  17. Ogur, G., Yuksel-Apak, M., Demiryont, M. Syndrome of congenital cutis laxa with ligamentous laxity and delayed development: report of a brother and sister from Turkey. Am. J. Med. Genet. 37: 6-9, 1990. [PubMed: 1700609] [Full Text: https://doi.org/10.1002/ajmg.1320370103]

  18. Patton, M. A., Baraitser, M. Cutis laxa and the Costello syndrome. J. Med. Genet. 30: 622 only, 1993. [PubMed: 8411045] [Full Text: https://doi.org/10.1136/jmg.30.7.622]

  19. Patton, M. A., Tolmie, J., Ruthnum, P., Bamforth, S., Baraitser, M., Pembrey, M. Congenital cutis laxa with retardation of growth and development. J. Med. Genet. 24: 556-561, 1987. [PubMed: 3669050] [Full Text: https://doi.org/10.1136/jmg.24.9.556]

  20. Philip, A. G. S. Cutis laxa with intrauterine growth retardation and hip dislocation in a male. J. Pediat. 93: 150-151, 1978. [PubMed: 565809] [Full Text: https://doi.org/10.1016/s0022-3476(78)80632-5]

  21. Reisner, S. H., Seelenfreund, M., Ben-Bassat, M. Cutis laxa associated with severe intrauterine growth retardation and congenital dislocation of the hip. Acta Paediat. Scand. 60: 357-360, 1971. [PubMed: 5579863] [Full Text: https://doi.org/10.1111/j.1651-2227.1971.tb06672.x]

  22. Sakati, N. O., Nyhan, W. L., Shear, C. S., Kattan, H., Akhtar, M., Bay, C., Jones, K. L., Schackner, L. Syndrome of cutis laxa, ligamentous laxity, and delayed development. Pediatrics 72: 850-856, 1983.

  23. Scherrer, D. Z., Alexandrino, F., Cintra, M. L., Sartorato, E. L., Steiner, C. E. Type II autosomal recessive cutis laxa: report of another patient and molecular studies concerning three candidate genes. Am. J. Med. Genet. 146A: 2740-2745, 2008. [PubMed: 18819152] [Full Text: https://doi.org/10.1002/ajmg.a.32345]

  24. Theopold, W., Wildhack, R. Dermatochalasis in Rahmen multipler Abartungen. Mschr. Kinderheilk. 99: 213-218, 1951.

  25. Van Maldergem, L., Ogur, G., Yuksel, M. Facial anomalies in congenital cutis laxa with retarded growth and skeletal dysplasia. (Letter) Am. J. Med. Genet. 32: 265 only, 1989. [PubMed: 2929668] [Full Text: https://doi.org/10.1002/ajmg.1320320229]

  26. Van Maldergem, L., Yuksel-Apak, M., Kayserili, H., Seemanova, E., Giurgea, S., Basel-Vanagaite, L., Leao-Teles, E., Vigneron, J., Foulon, M., Greally, M., Jaeken, J., Mundlos, S., Dobyns, W. B. Cobblestone-like brain dysgenesis and altered glycosylation in congenital cutis laxa, Debre type. Neurology 71: 1602-1608, 2008. [PubMed: 18716235] [Full Text: https://doi.org/10.1212/01.wnl.0000327822.52212.c7]

  27. Wu, X., Steet, R. A., Bohorov, O., Bakker, J., Newell, J., Krieger, M., Spaapen, L., Kornfeld, S., Freeze, H. H. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nature Med. 10: 518-523, 2004. [PubMed: 15107842] [Full Text: https://doi.org/10.1038/nm1041]

  28. Zlotogora, J. Wrinkly skin syndrome and the syndrome of cutis laxa with growth and developmental delay represent the same disorder. (Letter) Am. J. Med. Genet. 85: 194 only, 1999. [PubMed: 10406678] [Full Text: https://doi.org/10.1002/(sici)1096-8628(19990716)85:2<194::aid-ajmg19>3.0.co;2-p]


Contributors:
Cassandra L. Kniffin - updated : 3/14/2013
Nara Sobreira - updated : 1/29/2013
Marla J. F. O'Neill - updated : 1/31/2012
Marla J. F. O'Neill - updated : 1/27/2010
Cassandra L. Kniffin - updated : 7/21/2009
Cassandra L. Kniffin - updated : 3/24/2008
Victor A. McKusick - updated : 1/29/2008
Victor A. McKusick - updated : 7/20/1999

Creation Date:
Victor A. McKusick : 6/3/1986

Edit History:
alopez : 07/21/2021
alopez : 03/27/2017
carol : 10/14/2016
carol : 10/19/2015
carol : 9/30/2015
joanna : 7/18/2014
carol : 3/18/2013
terry : 3/14/2013
ckniffin : 3/14/2013
carol : 1/29/2013
alopez : 1/31/2012
alopez : 1/26/2012
alopez : 1/20/2012
joanna : 5/17/2011
wwang : 1/28/2010
terry : 1/27/2010
wwang : 9/3/2009
wwang : 8/12/2009
ckniffin : 7/29/2009
ckniffin : 7/21/2009
carol : 11/25/2008
terry : 6/4/2008
carol : 5/2/2008
carol : 5/2/2008
ckniffin : 3/24/2008
alopez : 2/8/2008
terry : 1/29/2008
alopez : 5/23/2006
carol : 4/20/2006
carol : 4/19/2006
ckniffin : 4/10/2006
jlewis : 8/2/1999
jlewis : 8/2/1999
terry : 7/20/1999
pfoster : 8/18/1994
carol : 4/15/1994
mimadm : 2/19/1994
supermim : 3/16/1992
carol : 10/23/1990
supermim : 3/20/1990